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Purpose: To investigate the learning curve for robot-assisted laparoscopic radical pros-
tatectomy (RALP) for pathologic T2 disease, we examined differences in perioperative 
outcomes according to time period.
Materials and Methods: Between July 2005 and June 2008, a total of 307 consecutive 
patients underwent RALP for prostate cancer and 205 patients had pathologic T2 
disease. Patients were grouped into 6-month time periods. We collected and examined 
the patient’s perioperative data including age, body mass index (BMI), prostate-specific 
antigen (PSA), operation time, estimated blood loss, and positive surgical margin.
Results: There were no significant differences among the groups in age (p=0.705), BMI 
(p=0.246), PSA (p=0.425), or prostate volume (p=0.380). Operation time (p＜0.001) and 
estimated blood loss (p＜0.001) decreased significantly with time. The positive surgical 
margin rate also showed a decreasing trend, but this was not significant (p=0.680).
Conclusions: Operation time and estimated blood loss had a steep learning curve during 
the early 24 cases and then stabilized. A positive surgical margin rate, however, did 
not have a significant learning curve, although the positive surgical margin decreased 
continuously.
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INTRODUCTION
Recently, robotic systems have been introduced to various 
surgical fields, including urologic surgery. In 2001, Binder 
and Kramer performed the first robot-assisted laparo-
scopic prostatectomy (RALP)  [1]. In 2005, the first domes-
tic RALP was performed with the da Vinci
TM robot system 
[2]. Cases of RALP are increasing abruptly as the robotic 
equipment becomes more widely used.
In general, robotic surgery has been considered to have 
a short learning curve in comparison with laparoscopic 
surgery. However, only a few reports have been published 
on the learning curve for RALP. Also, because most of the 
studies published previously described all patients who 
had undergone RALP, the inclusion of more patients with 
pathologic T3 disease over a certain period of time could re-
sult in selection bias that would negatively influence the 
results.
The purpose of this study was to investigate the learn-
ing curve of RALP for pathologic T2 disease by evaluating 
differences in perioperative outcomes according to time 
period.
MATERIALS AND METHODS
Between July 2005 and June 2008, a total of 307 consec-
utive patients had undergone RALP for prostate cancer. Of 
those men, 205 patients with diagnosed pathologic T2 dis-
ease were enrolled in this study. The da Vinci
TM robot sys-
tem (Intuitive Surgical Inc., Sunnyvale, USA) was used 
from July 2005 through May 2007 and the da Vinci S
TM ro-
bot system was used from June 2007 through June 2008. 
The total period of our study was 36 months, which was div-
ided into 6-month periods. The numbers of patients who 
underwent RALP during each 6 months were 7, 17, 33, 49, 
35, and 60 patients, respectively.
All patients had prostate cancer diagnosed by trans-
rectal ultrasound-guided prostate needle biopsy. For stag-
ing a workup, whole-body bone scan and either abdominal 
computed tomography (CT) or prostate magnetic reso-
nance imaging (MRI) were performed. The TNM 2002 clas-
sification was used for staging the operative specimens.Korean J Urol 2010;51:30-33
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FIG. 1. Operation time. RALP: robot-assisted laparoscopic radi-
cal prostatectomy.
FIG. 2. Estimated blood loss. RALP: robot-assisted laparoscopic
radical prostatectomy.
We collected all patients’ data including perioperative 
clinical outcomes and short-term surgical results. Preoper-
ative information collected included age, body mass index 
(BMI), prostate-specific antigen (PSA), and Gleason’s 
score. Intraoperative information collected included oper-
ation time and estimated blood loss. Operation time was 
defined as the time from initial incision to the completion 
of the last skin suture described in the anesthesia report, 
and estimated blood loss was calculated by the anes-
thesiologist. The postoperative information collected in-
cluded pathologic results, margin status, postoperative 
complications, duration of hospitalization, and duration of 
catheterization.
All surgeries were performed by only one surgeon by use 
of the transperitoneal approach. The ports for the da 
Vinci
TM robot system and laparoscopic tools were placed 
and RALP was performed as previously reported [3]. 
Except for the initial 15 patients, all other patients under-
went pelvic lymphadenectomy. Pelvic lymph node dis-
section was performed bilaterally in the external iliac, ob-
turator, and infraobturator areas.
Statistical analysis was performed by using SPSS ver-
sion 17.0 (SPSS Inc, Chicago, USA) by applying ANOVA, 
chi-square test, and Spearman’s rank correlation test. 
Differences were considered statistically significant at p＜ 
0.05.
RESULTS
From July 2005 to June 2008, the mean age of the total 205 
patients with diagnosed pathologic T2 prostate cancer af-
ter RALP was 63±8 years. The patients’ mean BMI was 
24.76±2.52 kg/m
2. The preoperative mean PSA value was 
12.72±50.77 ng/ml, and the average Gleason’s score was 
6.6 (range, 3-9). Mean prostate volume was 32.3±13.4 g. 
There were no significant differences in age (p=0.705), BMI 
(p=0.246), PSA (p=0.425), preoperative Gleason’s score 
(p=0.201), or prostate volume (p=0.380) among the 6- 
month time periods.
The overall mean operation time including robot in-
stallation and pelvic lymphadenectomy was 210±46 min, 
and mean operation time decrease as the number of cases 
increased (Spearman’s rho −0.268, p＜0.001). The mean 
operation time of each period was 335±64, 230±52, 215±38, 
199±31, 202±28, and 200±43 min, respectively, and there 
was a significant difference between the first period and the 
second to sixth periods (p＜0.001). However, there were no 
significant differences among the second to sixth periods 
(Fig. 1).
The mean volume of estimated blood loss was 337±287 
ml, and estimated blood loss also decreased as the number 
of cases increased (Spearman’s rho −0.188, p＜0.007). The 
mean estimated blood loss of each 6-month period was 
943±988, 302±164, 424±240, 295±200, 336±229, and 266± 
62 ml, respectively. Similar to the mean operation time, 
there was a significant difference between the first period 
and the second to sixth periods (p＜0.001), but there were 
no significant differences among the second to sixth periods 
(Fig. 2).
In all patients, including those with pathologic T3 pros-
tate cancer, the mean operation time was 332±60, 231±50, 
216±40, 203±35, 198±25, and 202±42 minutes, respec-
tively, and it differed significantly between the first and 
second to sixth periods (p＜0.001) (Fig. 1). Mean estimated 
blood loss was 1,013±936, 299±163, 487±402, 321±215, 
318±241, and 286±172 ml, respectively, and it also differed 
significantly between the first and second to sixth periods 
(p＜0.001) (Fig. 2). The first four patients (2%) in the series 
received blood transfusions.
The mean postoperative Gleason’s score was 6.6 (range, 
4-9), and the percentage of patients with a positive surgical 
margin was 13.2%. The positive surgical margin rate in the 
initial first year was 20.8%, and the rate declined with each 
period: 15.2%, 14.0%, 11.4%, and 9.5%, respectively (Fig. 
3), but there was no significant difference among the peri-
ods (p=0.680). The mean duration of hospitalization was Korean J Urol 2010;51:30-33
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FIG. 3. Positive surgical margin. RALP: robot-assisted la-
paroscopic radical prostatectomy.
5.1±3.0 days, and the mean duration of catheterization was 
11.4±4.0 days.
DISCUSSION
Since Binder and Kramer first reported RALP in 2001 [1], 
RALP has come into wide use at a rapid rate as a result of 
its various technical advantages and short-term oncologic 
outcomes comparable with those of open radical prostatec-
tomy and laparoscopic radical prostatectomy.
When a new surgical technique is introduced, it is com-
pared with previous surgical techniques in terms of pre-
operative, intraoperative, and postoperative variables to 
assess its clinical and oncologic outcomes. Operation time, 
estimated blood loss, and positive surgical margin rate are 
important in the assessment of clinical and oncologic 
outcomes.
Initial RALP data showed relatively wide ranges in op-
eration time: total operation time of 540 minutes (by Binder 
and Kramer [1]), robot installation time of 93 minutes and 
operation time of 222 minutes (by Pasticier et al [4]), and 
robot installation time of 0.95 hour and operation time of 
4.8 hour (by Menon et al [5]). However, these operation 
times were reported in initial studies with sample sizes of 
fewer than 30 patients. As centers began performing more 
RALP procedures, larger studies demonstrated shorter op-
erative times. Ahlering et al reported that, as the operator’s 
experience accumulated, mean operation time was re-
duced to less than 4 hours after 12 cases of RALP with a 
mean operative time of 3.45 hours [6]. Thus, this report sug-
gests that an operator without any experience with laparo-
scopic surgery can achieve a fast learning curve in perform-
ing RALP. Furthermore, Zorn et al analyzed 150 cases of 
RALP performed by skilled laparoscopic urologic surgeons 
[7]. In their report, the initial decrease in operative time 
to less than 4 hours was achieved after 120 cases and it was 
after 25 cases of RALP, without conversion to open radical 
prostatectomy and with no complications. Thus, Zorn et al 
concluded that inexperience in laparoscopy does not influ-
ence the learning curve. Mean operation time after the 
learning curve in other reports ranged from 141 to 250 mi-
nutes, and a gradual decline in operation time was also 
shown [8,9]. Our first case of RALP took 80 minutes for ro-
bot installation and 420 minutes for the operation [10]. 
However, as our number of experiences grew, we saw a ma-
jor decline in operation time. Also, our initial decrease in 
operation time during the first 24 cases and gradual de-
crease after subsequent cases were similar with prior studies.
Low blood loss is often considered one of the main ad-
vantages of minimally invasive surgery. Pneumoperi-
toneum is thought to be a positive factor in decreasing the 
amount of blood loss. Ahlering et al compared open radical 
prostatectomy with RALP and stated that there were sig-
nificant differences in blood loss between the two groups 
(418 ml vs. 103 ml) [11]. Furthermore, Tewari et al reported 
that blood loss was greater in open radical prostatectomy 
than in RALP (910 ml vs. 150 ml) [12]. According to data 
from larger studies with sample sizes of over 30 patients, 
mean blood loss ranged from 103 to 570 ml [11,13]. Jaffe 
et al analyzed 293 cases of RALP, subdividing the patients 
into 3 groups (before the first 12 cases, 13 to 188 cases, and 
after 189 cases) and showed that mean blood loss differed 
significantly among the 3 groups (242, 165, and 134 ml, re-
spectively) [14]. In domestic studies, Ban et al divided pa-
tients into 2 groups (the first 15 cases and cases 16 to 50) 
and showed a significant difference in blood loss between 
the 2 groups (464 and 328 ml) [15]. As shown in our study, 
there was an abrupt decrease in estimated blood loss and 
a gradual decrease after the breakpoint.
In the present study, there was no significant difference 
in operation time or estimated blood loss between the pa-
tients with pathologic T2 prostate cancer and the total 
group of patients including those with pathologic T3 pros-
tate cancer. Our results could be due to the fact that only 
4 patients with pathologic T3 prostate cancer underwent 
RALP in the first and second periods, which showed steep 
learning curves. In addition, our results could be due to an 
inclusion of more patients with pathologic T3 prostate can-
cer after the surgeon achieved the learning curve.
Transfusion rates have been reported to range from 0% 
[5,11,12] to as high as 18% [16] in patients with RALP, but 
this rate has been shown to be significantly lower than with 
open radical prostatectomy. Tewari et al demonstrated 
this in comparing standard open radical prostatectomy 
with RALP [12]. They found a transfusion rate difference 
of 67% in their open group, compared with 0% in their ro-
botic series.
There has not been enough long-term follow-up on onco-
logic outcomes of RALP. However, margin status can verify 
the surgical aspects of oncologic outcomes. Several studies 
comparing RALP with open radical prostatectomy and lap-
aroscopic radical prostatectomy have demonstrated sim-
ilar rates of positive surgical margin. After reviewing the 
current literature, Hegarty and Kaouk reported the pos-
itive margin rate of the open procedure, laparoscopic proce-
dure, and RALP to be 13-21%, 16-26%, and 6-23%, Korean J Urol 2010;51:30-33
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respectively. Also, the positive margin rate is directly influ-
enced by the stage of prostate cancer [17]. Wolfram et al re-
ported a positive margin rate of 12.7% for pathologic T2 tu-
mors and a positive margin rate of 42% for pathologic T3 
tumors [9]. On the contrary, Jaffe et al reported rates of 23% 
for pathologic T2 tumors and 15% for pathologic T3 tumors 
[14]. We consider these differences to be because the pos-
itive margin rate is influenced directly not only by prostate 
cancer stage but also by operative techniques and nerve- 
sparing procedures. In addition, the surgeon’s learning 
curve and each proportion of cancer stages per time period 
could have influenced the positive margin rate, because 
most studies are of initial experiences with RALP or 
short-term surgical outcomes. Our study was limited to 
pathologic T2 stage and showed an average positive mar-
gin rate of 13.2%, which is comparable with previously re-
ported positive margin rates with the open procedure or 
laparoscopic procedure. Also, positive margin rates show-
ed a tendency toward gradual decline as the surgeon’s expe-
riences accumulated. In our study, positive margin rates 
could not be statistically analyzed according to whether 
nerve-sparing procedures were performed because of the 
relatively small numbers of RALP performed without 
nerve-sparing procedures.
The results of the steep learning curve and positive mar-
gin rate in our study were not significantly different from 
studies of conventional open or laparoscopic procedures 
and are similar to the previous literature. We presume that 
the absence of tactile feedback, which has been the most 
troublesome disadvantage of RALP, will be overcome in the 
near future. Also, the continuous development of tech-
nologies in robotic systems should result in the surgeon’s 
learning curve for RALP being achieved faster.
We intended to evaluate the clinical outcomes of RALP 
for pathologic T2 diseases and to investigate the learning 
curve. However, our study had several limitations. We as-
sessed the learning curve based on a single surgeon’s 
experience. Subjective variables such as surgeon’s experi-
ences in open and laparoscopic procedures and experiences 
in robotic surgery training abroad are included in this 
study. Thus, the results of our study cannot be applied to 
other surgeons in general. Furthermore, we evaluated the 
results of RALP on the basis of each period of time and as-
sessed the learning curve. Differences in outcome may 
have existed according to the numbers of RALP procedures 
performed during each period of time. Better outcomes 
might have resulted if a relatively large number of RALP 
procedures were performed in a single period of time, thus 
enhancing the surgeon’s proficiency.
CONCLUSIONS
Our study showed a gradual decrease in operative time and 
estimated blood loss during RALP with the da Vinci
TM robot 
system. In addition, operation time and estimated blood 
loss had steep learning curves during the early 24 cases and 
then stabilized. Even though there was no significant dif-
ference in the positive surgical margin rate, a continuous 
decrease in the positive surgical margin rate was observed 
in our study. The short-term outcomes of our study verify 
the achievement of an excellent learning curve in RALP.
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